FAKTOR-OPTIONSSCHEIN - BECTON DICKINSON AND CO. Share Price

Certificat

DE000MC2VTT3

Market Closed - Bid/Ask 19:57:28 24/06/2024 BST Pre-market 07:26:49
0.167 EUR -3.47% Intraday chart for FAKTOR-OPTIONSSCHEIN - BECTON DICKINSON AND CO. 0.168 +0.60%
Current month+12.08%
1 month+15.17%
Date Price Change
24/06/24 0.167 -3.47%
21/06/24 0.173 -1.14%
20/06/24 0.175 +14.38%
19/06/24 0.153 -2.55%
18/06/24 0.157 +1.95%

Delayed Quote Börse Stuttgart

Last update June 24, 2024 at 07:57 pm

More quotes

Static data

Product typeExotische Produkte
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN MC2VTT
ISINDE000MC2VTT3
Date issued 25/07/2019
Strike 188.8 $
Maturity Unlimited
Parity 268.26 : 1
Emission price 10
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 13.34
Lowest since issue 0.129
Spread 0.008
Spread %4.65%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
235.9 USD
Average target price
279.2 USD
Spread / Average Target
+18.34%
Consensus